JP2010502586A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502586A5
JP2010502586A5 JP2009526219A JP2009526219A JP2010502586A5 JP 2010502586 A5 JP2010502586 A5 JP 2010502586A5 JP 2009526219 A JP2009526219 A JP 2009526219A JP 2009526219 A JP2009526219 A JP 2009526219A JP 2010502586 A5 JP2010502586 A5 JP 2010502586A5
Authority
JP
Japan
Prior art keywords
phenyl
dihydroxy
abl
bcr
propenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009526219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/053308 external-priority patent/WO2008026125A2/en
Publication of JP2010502586A publication Critical patent/JP2010502586A/ja
Publication of JP2010502586A5 publication Critical patent/JP2010502586A5/ja
Pending legal-status Critical Current

Links

Images

JP2009526219A 2006-09-01 2007-08-20 コーヒー酸と誘導体の抗ガン用途 Pending JP2010502586A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84206006P 2006-09-01 2006-09-01
PCT/IB2007/053308 WO2008026125A2 (en) 2006-09-01 2007-08-20 Anti cancer use of caffeic acid and derivatives

Publications (2)

Publication Number Publication Date
JP2010502586A JP2010502586A (ja) 2010-01-28
JP2010502586A5 true JP2010502586A5 (enExample) 2010-10-07

Family

ID=39015871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526219A Pending JP2010502586A (ja) 2006-09-01 2007-08-20 コーヒー酸と誘導体の抗ガン用途

Country Status (12)

Country Link
US (1) US20100010002A1 (enExample)
EP (1) EP2061452B1 (enExample)
JP (1) JP2010502586A (enExample)
AT (1) ATE530176T1 (enExample)
AU (1) AU2007290960B2 (enExample)
CA (1) CA2662126A1 (enExample)
DK (1) DK2061452T3 (enExample)
ES (1) ES2376277T3 (enExample)
IL (1) IL197262A0 (enExample)
PT (1) PT2061452E (enExample)
TW (1) TW200812955A (enExample)
WO (1) WO2008026125A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722665B2 (en) 2008-11-07 2014-05-13 Council Of Scientific & Industrial Research Cinnamido-pyrrolo[2,1-C][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
CN101456890B (zh) * 2008-12-17 2011-02-02 中南大学 白血病bcr/abl融合基因mRNA的特异性抑制剂
EP2427416B1 (en) 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
BR112012021476A2 (pt) 2010-02-25 2019-09-24 Piramal Entpr Ltd composto, processo para preparação do composto, composição farmacêutica compreendendo uma quantidade terapeuticamente eficaz do composto e emprego de tal composto
CN105997967B (zh) 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
US20140127316A1 (en) * 2011-05-20 2014-05-08 New York University Propolis and caffeic acid phenethyl ester and uses thereof
US20160194718A1 (en) * 2013-05-21 2016-07-07 Dana-Farber Cancer Institute, Inc. Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using Histone H3K27ME3 Biomarkers and Modulators
WO2017161093A1 (en) * 2016-03-17 2017-09-21 Musc Foundation For Research Development Caffeic acid derivatives and uses thereof
BR112022004890A2 (pt) * 2019-09-17 2022-06-07 Enzene Biosciences Ltd Composições para uso na inibição de src quinase e no tratamento e na prevenção de distúrbios associados
EP4023301A3 (en) * 2020-12-29 2022-09-07 Huscion Co., Ltd. Piperlongumine-based compound and immuno regulator comprising the same
US20240109855A1 (en) * 2021-01-14 2024-04-04 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Anti-quorum sensing, anti-biofilm, and inflammation attenuating compounds, compositions, and methods of using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216024A (en) * 1987-07-28 1993-06-01 Baylor College Of Medicine Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
US5008441A (en) * 1987-08-04 1991-04-16 The Trustees Of Columbia University In The City Of New York Caffeic acid esters and methods of producing and using same
DE60206531T2 (de) * 2002-05-31 2006-07-13 Council Of Scientific & Industrial Research Ein kräutermolekül als potentielles anti-leukämisches arzneimittel
WO2004004708A1 (en) * 2002-07-08 2004-01-15 Council Of Scientific And Industrial Research A pharmaceutical composition useful for treating chronic myeloid leukemia
US20040006138A1 (en) * 2002-07-08 2004-01-08 Council Of Scientific Pharmaceutical composition useful for treating chronic myeloid leukemia
US20050282892A1 (en) * 2002-07-08 2005-12-22 Santu Bandyopadhyay Pharmaceutical composition useful for treating chronic myeloid leukemia
US20070161704A1 (en) * 2002-07-08 2007-07-12 Council Of Scientific And Industrial Research Pharmaceutical composition useful for treating chronic myeloid leukemia
WO2005099721A2 (en) * 2004-04-15 2005-10-27 The Regents Of The University Of California Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
US20060045887A1 (en) 2004-08-25 2006-03-02 Gavish-Galilee Bio Applications Ltd. Mushroom extracts having anticancer activity

Similar Documents

Publication Publication Date Title
JP2010502586A (ja) コーヒー酸と誘導体の抗ガン用途
US8691829B2 (en) Treatment of liver disorders with PI3K inhibitors
US9421211B2 (en) N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
WO2013116786A1 (en) Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer
US12280055B2 (en) Combination therapies
CN101273989B (zh) 一类小檗胺衍生物及其盐的应用
KR20210046700A (ko) 히스톤 데아세틸라제 억제제와 단백질 키나제 억제제의 조합 및 이의 약제학적 용도
CN110785170B (zh) 脂肪细胞的治疗
Choudhury et al. PIM1 kinase and its diverse substrate in solid tumors
US11465978B2 (en) Anthranilic amides and the use thereof
JP5289310B2 (ja) 微小管破壊剤及びそれを含有する癌細胞増殖抑制剤
CN106518809A (zh) 丙酮酸脱氢酶激酶抑制剂及其应用
JP2013515766A (ja) イマチニブジクロロ酢酸塩及びそれを含む抗癌剤組成物
US20160213729A1 (en) Filipendula vulgaris extract and uses thereof
CN106905185A (zh) 酰肼类ido1抑制剂及其医药用途
TWI434680B (zh) 二萜類化合物於治療攝護腺癌之用途
AU2015352041B2 (en) Titled extracts of Cynara scolymus and uses thereof
CA3049017A1 (en) Tryptamine-based ship inhibitors for the treatment of cancer
Lee et al. Anticatabolic effects of morin through the counteraction of interleukin-1β-induced inflammation in rat primary chondrocytes
CN112513000A (zh) 新型联苯衍生物化合物及其用途
TW201532602A (zh) 單胺氧化酶抑制劑及其共軛物於治療腦癌之用途
CN111603466B (zh) 一种乙酮类化合物在制备治疗肿瘤药物中的应用
US20150232456A1 (en) Aurora kinase inhibitors
US11576892B2 (en) Benzopyran derivatives and uses thereof
CN113952343A (zh) 隐丹参酮在抑制stat5蛋白磷酸化方面的应用